Abstract
In addition to producing antinociception, opioids exert profound effects on body temperature. This study aimed at comparing antinociceptive and hyperthermic responses between two groups of μ-opioid receptor agonists: fentanyl (4-anilinopiperidine-type) and morphine (phenanthrene-type) derivatives in rats. Analgesic activity was assessed by tail immersion test and the body temperature by insertion of a thermometer probe into the colon. Fentanyl (F), (±)-cis-3-methyl fentanyl (CM), (±)-cis-3-carbomethoxy fentanyl (C), (±)trans-3-carbomethoxy fentanyl (T) and (±)-cis-3 butyl fentanyl (B) produced dose-dependent increase in antinociception and hyperthermia. The relative order of analgesic potency was: CM(11.27)>F(1)>C(0.35)≥T(0.11)≥B(0.056). Similar to this, the relative order of hyperthermic potency was: CM(8.43)>F(1)>C(0.46)≥T(0.11)≥B(0.076). Morphine (M), oxycodone (O), thebacon (T) and 6,14-ethenomorphinan-7-methanol, 4,5-epoxy-6-fluoro-3-hydroxy-α,α,17-trimethyl-, (5α,7α) (E) also produced dose-dependent increase in antinociception and hyperthermia. Among morphine derivatives the relative order of analgesic potency was: E(56)>O(5)≥T(2.6)>M(1), and similar to this, the relative order of hyperthermic potency was: E(37)>O(3)≥T(2.3)>M(1). Morphine (phenanthrene-type) and fentanyl (4-anilinopiperidine-type) derivatives produced hyperthermia in rats at doses about 2 times lower, and 6–11 times higher, than their median antinociceptive doses, respectively. This study is first to identify difference between these two classes of opioid drugs in their potencies in producing hyperthermia. Further studies are needed to clarify the significance of these findings.
Similar content being viewed by others
References
Adler, M.W., and E.B. Geller. 1989. Thermoregulation and the opioid system. NIDA Research Monograph 95: 180–185.
Baker, A.K., and T.F. Meert. 2002. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. Journal of Pharmacology and Experimental Therapeutics 302: 1253–1264.
Benamar, K., M. Yondorf, V.T. Barreto, E.B. Geller, and M.W. Adler. 2007. Deletion of mu-opioid receptor in mice alters the development of acute neuroinflammation. Journal of Pharmacology and Experimental Therapeutics 323: 990–994.
Berenyi, S., Z. Toth, A. Sepsi, A. Zekany, S. Gyulai, and S. Makleit. 1995. Synthesis and biological evaluation of some halogenated 6,14-ethenomorphinan derivatives. Medicinal Chemistry Research 5(1): 26–32.
Bourne, H., and M. von Zastrow. 2007. Drug receptors & pharmacodynamics. In Basic and Clinical Pharmacology, ed. B.G. Katzung, 11–33. New York: The McGraw-Hill Companies Inc.
Cao, W.H., and S.F. Morrison. 2005. Brown adipose tissue thermogenesis contributes to fentanyl-evoked hyperthermia. American Journal of Physiology 288: 723–732.
Chen, X., D.B. McClatchy, E.B. Geller, R.J. Tallarida, and M.W. Adler. 2005. The dynamic relationship between mu and kappa opioid receptors in body temperature regulation. Life Sciences 78: 329–333.
Davis, M.P. 2012. Evidence from basic research for opioid combinations. Expert Opinion on Drug Discovery 7: 165–178.
Dietis, N., D.J. Rowbotham, and D.G. Lambert. 2011. Opioid receptor subtypes: fact or artifact? British Journal of Anaesthesia 107: 8–18.
Došen-Mićović, Lj., M. Ivanović, and V. Mićović. 2006. Steric interactions and the activity of fentanyl analogs at the mu-opioid receptor. Bioorganic & Medicinal Chemistry 14: 2887–2895.
Groer, C.E., C.L. Schmid, A.M. Jaeger, and L.M. Bohn. 2011. Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation. Journal of Biological Chemistry 286: 31731–31741.
Fraga, D., R.R. Machado, L.C. Fernandes, G.E. Souza, and A.R. Zampronio. 2008. Endogenous opioids: role in prostaglandin-dependent and -independent fever. American Journal of Physiology 294: 411–420.
Ivanović, M.D., I.V. Mićović, S. Vučković, M. Prostran, Z. Todorović, V.D. Kricojević, J.B. Djordjević, and Lj. Došen-Mićović. 2004. The synthesis and preliminary pharmacological evaluation of the racemic cis and trans 3-alkylfentanyl analogues. Journal of the Serbian Chemical Society 69: 511–526.
Janssen, P.A.J., C.J.E. Niemegeers, and J.G.H. Dony. 1963. The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneimittel-Forsch (Drug Research) 13: 502–507.
Kissin, I., R. Kerr, and L.R. Smith. 1983. Assessment of anaesthetic action of morphine and fentanyl in rats. Canadian Anaesthetists Society Journal 30: 623–628.
Lu, Y.F., H. Xu, L.Y. Liu-Chen, C. Chen, J.S. Partilla, G.A. Brine, F.I. Carroll, K.C. Rice, J. Lai, F. Porreca, W. Sadee, and R.B. Rothman. 1998. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor. Synapse (New York, NY) 28: 117–124.
Mićović, I.V., M.D. Ivanović, S. Vučković, D. Jovanović-Mićić, D. Beleslin, Lj. Došen-Mićović, and V.D. Kiricojević. 1998. 3-Carbomethoxy fentanyl: synthesis, pharmacology and conformational analysis. Heterocyclic Communications 4: 171–179.
Nozaki, C., B. Le Bourdonnec, D. Reiss, R.T. Windh, P.J. Little, R.E. Dolle, B.L. Kieffer, and C. Gavériaux-Ruff. 2012. δ-Opioid Mechanisms for ADL5747 and ADL5859 effects in mice: analgesia, locomotion, and receptor internalization. Journal of Pharmacology and Experimental Therapeutics 342: 799–807.
Pradhan, A.A., M.L. Smith, B.L. Kieffer, and C.J. Evans. 2012. Ligand-directed signaling within the opioid receptor family. British Journal of Pharmacology 167: 960–969.
Rawls, S.M., and K. Benamar. 2011. Effects of opioids, cannabinoids, and vanilloids on body temperature. Frontiers in Bioscience (Scholar Edition) 3: 822–845.
Rivero, G., J. Llorente, J. McPherson, A. Cooke, S.J. Mundell, C.A. McArdle, E.M. Rosethorne, S.J. Charlton, C. Krasel, C.P. Bailey, G. Henderson, and E. Kelly. 2012. Endomorphin-2: a biased agonist at the μ-opioid receptor. Molecular Pharmacology 82: 178–188.
Rives, M.L., M. Rossillo, L.Y. Liu-Chen, and J.A. Javitch. 2012. 6′-Guanidinonaltrindole (6′-GNTI) is a G protein-biased κ-opioid receptor agonist that inhibits arrestin recruitment. Journal of Biological Chemistry 287: 27050–27054.
Tomić, M.A., S.M. Vučković, R.M. Stepanović-Petrović, N.D. Ugrešić, M.S. Prostran, and B. Bošković. 2010. Synergistic interactions between paracetamol and oxcarbazepine in somatic and visceral pain models in rodents. Anesthesia and Analgesia 110: 1198–1205.
Tallarida, R.J., and R.B. Murray. 1986. Manual of pharmacologic calculations with computer programs. New York: Springer.
Vučković, S., M. Ivanović, M. Prostran, Z. Todorović, Z. Ristović, I. Micović, and D. Beleslin. 1998. Higher environmental temperature potentiates cataleptic effect of fentanyl in rats. Japanese Journal of Pharmacology 78: 523–527.
Vučković, S., M. Prostran, M. Ivanović, Z. Ristović, and R. Stojanović. 2000. Antinociceptive activity of the novel fentanyl analogue iso-carfentanil in rats. Japanese Journal of Pharmacology 84: 188–195.
Vučković, S., M. Prostran, M. Ivanović, Lj. Došen-Mićović, Z. Todorović, Z. Nešić, R. Stojanović, N. Divac, and Ž. Miković. 2009. Fentanyl analogs: structure-activity-relationship study. Current Medicinal Chemistry 16: 2468–2474.
Yang, P.K., M.B. Weinger, and S.S. Negus. 1992. Elucidation of dose-effect relationships for different opiate effects using alfentanil in the spontaneously ventilating rat. Anesthesiology 77: 153–161.
Acknowledgments
This work was supported by Ministry of Education, Science and Technological Development of Serbia (Grant No. 175023). The author would like to convey thanks to Alkaloid (Skopje, Macedonia) and University of Debrecen, Hungary, who gifted us some of the compounds tested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Savić Vujović, K.R., Vučković, S., Srebro, D. et al. A comparison of the antinociceptive and temperature responses to morphine and fentanyl derivatives in rats. Arch. Pharm. Res. 36, 501–508 (2013). https://doi.org/10.1007/s12272-013-0072-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-013-0072-z